Remarkably, rheumatoid arthritis patients that received the IL-1R antagonist Anakinra exhibited a roughly 330-fold increased rate of invasive GAS infections which included an elevated likelihood of life-threatening complications such as necrotizing fasciitis and sepsis [95]. Here, IL1R1 is linked to Sepsis.